New app aims to ease lung cancer treatment side effects at home
NCT ID NCT07632703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a home-based app for lung cancer patients on combination drug therapy. The app helps patients track symptoms, get personalized advice, and receive nurse support during treatment breaks. Researchers will see if it reduces symptom burden and improves quality of life compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Home-Based Intelligent Symptom Management Program (WeChat mini-program)
- What this could lead to
- If successful, this program could give lung cancer patients a practical tool to better manage symptoms at home, potentially improving their quality of life during treatment.
- What could go wrong
- This is a small feasibility study with only 60 participants, so results may not apply widely. The program relies on smartphone use, which may not suit all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection